Walleye Capital LLC Bio Path Holdings Inc Transaction History

Walleye Capital LLC

  • $54.3 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.36 - $1.78 $75,325 - $372,443
209,238 New
209,238 $77,000
Q1 2023

May 15, 2023
SELL
$1.39 - $2.26 $155,372 - $252,620
-111,779 Reduced 59.84%
75,024 $104,000
Q4 2022

Feb 14, 2023
BUY
$1.32 - $69.2 $246,579 - $12.9 Million
186,803 New
186,803 $282,000

About BIO-PATH HOLDINGS INC

BPTH Quotes by TradingView
  • Ticker BPTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,160,160
  • Market Cap $7.3M
  • Description
  • Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...
More about BPTH
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email